Original Article

Incidence Rates and Outcomes of Nodular and Superficial Spreading Melanoma along the Rural-Urban Continuum in Kentucky and Their Relationship to Provider Care Access

Authors: Doug McElroy PhD, Mason Towery BS, Seiry Molina-Lopez BS, Ruth Eastham BS, Sarah Grace Alexander BS, Natalie J. Mountjoy PhD

Abstract

Objectives: This study compared incidence rates, stage at presentation, and cause-specific mortality of nodular and superficial spreading melanoma along the rural-urban continuum in Kentucky. We compared resulting patterns in our data with sample demographic and other potential factors, including population by county and primary care provider rate.

Methods: Retrospective patient data were extracted from the Surveillance, Epidemiology, and End Results database from 2010 through 2017. These data were supplemented by environmental, demographic, and socioeconomic data derived from publicly accessible databases. Correlation and χ2 analyses were used to test for significant differences in outcome variables by US Department of Agriculture Rural-Urban Continuum Code (RUCC) categories and other potential predictor variables.

Results: Incidence rates by Kentucky county were not associated with RUCC or population; likewise, there was no relationship between stage at presentation and RUCC category. There was, however, a highly significant association between cause-specific mortality and RUCC; patients from rural areas were significantly more likely to die from melanoma than those in urban areas. This overall difference was due to differences in mortality for superficial spreading melanoma.

Conclusions: Our results suggest that a disparity in patients’ ability or tendency to access primary care and/or specialist providers postdiagnosis may be critical factors in determining the ultimate outcome of a melanoma diagnosis. Further studies should explore the availability of dermatologists and/or treatment options for melanoma in rural areas. Our data also provide additional support for inclusion of melanoma subtype in the American Joint Committee on Cancer guidelines.
Posted in: Skin Cancer3

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Linares MA, Zakaria A, Nizran P. Skin cancer. Prim Care 2015;42:645–659.
 
2. Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther 2019;20:1366–1379.
 
3. Naik PP. Cutaneous malignant melanoma: a review of early diagnosis and management. World J Oncol 2021;12:7–19.
 
4. Glanz K, Buller DB, Saraiya M. Reducing ultraviolet radiation exposure among outdoor workers: state of the evidence and recommendations. Environ Health 2007;6:22.
 
5. Vogel RI, Jewett PI, Ahmed RL, et al. Comparison of sun exposure and protection behaviors between urban and rural residents without a history of melanoma in the Midwestern United States. J Am Acad Dermatol 2022;86: 229–232.
 
6. Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005;97:195–199.
 
7. Coory M, Smithers M, Aitken J, et al. Urban-rural differences in survival from cutaneous melanoma in Queensland. Aust N Z J Public Health 2006;30:71–74.
 
8. Henley SJ, Anderson RN, Thomas CC, et al. Invasive cancer incidence, 2004-2013, and deaths, 2006-2015, in nonmetropolitan and metropolitan counties—United States. MMWR Surveill Summ 2017;66(SS-14):1–13.
 
9. Shellenberger AR, Johnson TM, Fayaz F, et al. Disparities in melanoma incidence and mortality in rural versus urban Michigan. Cancer Rep (Hoboken) 2023;6:e1713.
 
10. Haluza D, Simic S, Moshammer H. Temporal and spatial melanoma trends in Austria: an ecological study. Int J Environ Res Public Health 2014;11:734–748.
 
11. US Department of Health and Human Services. Health professional shortage areas (HPSAs) and medically underserved areas/populations (MUA/P) shortage designation types. https://www.hhs.gov/guidance/document/hpsa-and-muap-shortage-designation-types. Published August 1, 2019. Accessed July 14, 2023.
 
12. US Health Resources and Services Administration. MUA find.https://data.hrsa.gov/tools/shortage-area/mua-find. Accessed July 14, 2023.
 
13. US Health Resources and Services Administration. HSPA find. https://data.hrsa.gov/tools/shortage-area/hpsa-find. Accessed July 14, 2023.
 
14. Lideikaitė A, Mozūraitienė J, Letautienė S. Analysis of prognostic factors for melanoma patients. Acta Med Litu 2017;24:25–34.
 
15. Allais BS, Beatson M, Wang H, et al. Five-year survival in patients with nodular and superficial spreading melanomas in the US population. J Am Acad Dermatol 2021;84:1015–1022.
 
16. Singh P, Kim HJ, Schwartz RA. Superficial spreading melanoma: an analysis of 97702 cases using the SEER database. Melanoma Res 2016;26:395–400.
   
18. American Cancer Society Cancer Statistics Center. Melanoma of the skin. https://www.cancer.org/cancer/types/melanoma-skin-cancer.html. Accessed July 14, 2023.
 
19. US Department of Agriculture Economic Research Service. Rural-urban continuum codes. https://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx. Accessed July 14, 2023.
 
20. Centers for Disease Control and Prevention. National Environmental Public Health Tracking Network. https://ephtracking.cdc.gov/. Accessed July 14, 2023.
 
21. University of Wisconsin Population Health Institute. County health rankings and roadmaps. https://www.countyhealthrankings.org/health-data/kentucky?year=2024. Accessed July 14, 2023.
 
22. Centers for Disease Control and Prevention. United States Cancer Statistics. https://www.cdc.gov/cancer/uscs/about/data-briefs/no28-melanoma-2018.htm. htm. Accessed August 3, 2023.
 
23. Eide MJ, Weinstock MA, Clark MA. The association of physician-specialty density and melanoma prognosis in the United States 1988 to 1993. J Am Acad Dermatol 2009;60:51–58.
 
24. Aneja S, Aneja S, Bordeaux JS. Association of increased dermatologist density with lower melanoma mortality. Arch Dermatol 2012;148:174–178.
 
25. Ryes-Cortez CA, Goodwin JS, Freeman JL. The effect of socioeconomic factors on incidence, stage at diagnosis and survival of cutaneous melanoma. Med Sci Monit 2005;11:RA163-RA172.
 
26. Sitenga JL, Aird G, Ahmed A, et al. Socioeconomic status and survival for patients with melanoma in the United States: an NCDB analysis. Int J Dermatol 2018;57:1149–1156.